Are you Dr. Cook?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1330 Rockefeller Ave
Ste 520
Everett, WA 98201Phone+1 425-267-5200
Summary
- Dr. James Cook Jr., MD is a vascular surgeon in Everett, Washington. He is currently licensed to practice medicine in Washington, Utah, and Texas. He is affiliated with Providence Regional Medical Center Everett, EvergreenHealth Monroe, and Providence Swedish Edmonds.
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Vascular Surgery - Independent, 1989 - 1991
University of Utah HealthResidency, Surgery, 1981 - 1987
University of Texas Southwestern Medical SchoolClass of 1981
Certifications & Licensure
WA State Medical License 1991 - 2025
UT State Medical License 1982 - 1988
TX State Medical License 1981 - 1987
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 6 citationsRationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies.Lalit K Golani, Md Yeunus Mian, Taukir Ahmed, Kamal P Pandey, Prithu Mondal
Bioorganic & Medicinal Chemistry Letters. 2022-04-15 - 5 citationsPositive modulation of α5GABAA receptors leads to dichotomous effects in rats on memory pattern and GABRA5 expression in prefrontal cortex and hippocampus.Anja Santrač, Bojan Batinić, Tamara Timic Stamenic, Jovana Aranđelović, Dishary Sharmin
Behavioural Brain Research. 2022-01-07 - 2 citationsIdentification and Quantification of MIDD0301 metabolites.M S Rashid Roni, Nicolas M Zahn, Brandon N Mikulsky, Daniel A. Webb, Yeunus Mian
Current Drug Metabolism. 2021-12-01
Grant Support
- Targeting System Xc- For The Treatment Of AddictionNational Institute On Drug Abuse2009–2010
- Design And Synthesis Of Anxioselective AnxiolyticsNational Institute Of Mental Health2006–2010
- Development Of Compounds Targeting Xc- For The Treatment Of SchizophreniaNational Institute Of Mental Health2008–2009
- Flow Cytometry FacilityNational Cancer Institute2005–2009
- Selective Anxiolytics VIA Bzr Subtype Specific LigandsNational Institute Of Mental Health1997–2005
- Rigid Probes--Modeling Selective Anxiolytics For BzrNational Institute Of Mental Health1994–1995
- Rigid Probes: Modeling Selective Anxiolytics For BzrNational Institute Of Mental Health1991–1993
- Beta-Carbolines: Valium Agonists And AntagonistsNational Institute Of Mental Health1988–1992
- Characterization Of BZ Receptors &Punished RespondingNational Institute On Drug Abuse1988
- Analytical High Pressure Liquid ChromatographyNational Institute Of Environmental Health Sciences1988
- Stereospecific Approach To Macroline-Related AlkaloidsNational Institute Of Neurological Disorders And Stroke1986–1988
- B-Carbolines: Search For Valium Agonists &AntagonistsNational Institute Of Mental Health1985–1987
Professional Memberships
- Member
- Member
